A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Status: | Recruiting |
---|---|
Conditions: | Colitis, Colitis, Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 4/5/2019 |
Start Date: | July 18, 2018 |
End Date: | August 23, 2023 |
Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
Email: | ClinicalTrials.gov@lilly.com |
Phone: | 1-317-615-4559 |
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
This study designed to evaluate the long-term efficacy and safety of mirikizumab in
participants with moderately to severely active ulcerative colitis (UC).
participants with moderately to severely active ulcerative colitis (UC).
- Inclusion Criteria
- Participants from Study AMAC (NCT02589665) or AMBG (NCT #:TBD) who have had at
least one study drug administration and have not had early termination of study
drug.
- Female participants must agree to contraception requirements.
- Exclusion Criteria
- Participants must not have developed a new condition, including cancer in the
originator study.
- Participants must not have any important infections including, but not limited
to, hepatitis B, hepatitis C, HIV/AIDS, and active tuberculosis (TB) during
either originator study
- Participants may not have received surgery for UC in the originator study or are
likely to require surgery for treatment of UC during the study.
- Participants must not have developed adenomatous polyps during the originator
study that have not been removed prior to the start of this study.
We found this trial at
13
sites
9500 Gilman Dr
La Jolla, California 92093
La Jolla, California 92093
(858) 534-2230
Principal Investigator: William J Sandborn
Phone: 858-657-5284
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
Click here to add this to my saved trials
4800 Belfort Rd # 2
Jacksonville, Florida 32256
Jacksonville, Florida 32256
Principal Investigator: Mark R Fleisher
Phone: 904-398-3262
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 764-1817
Principal Investigator: Peter D Higgins
Phone: 734-647-2964
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials
Chesterfield, Michigan 48098
Principal Investigator: Ronald P Fogel
Phone: 586-598-3329
Click here to add this to my saved trials
Ciudad Autonoma De Buenos Air,
Principal Investigator: Emiliano Tron
Phone: 541145143410
Click here to add this to my saved trials
Hialeah Gardens, Florida 33016
Principal Investigator: Lucky Flores
Phone: 786-483-7856
Click here to add this to my saved trials
Inverness, Florida 34452
Principal Investigator: Paul A Hellstern
Phone: 352-341-2100
Click here to add this to my saved trials
Monroe, Louisiana 71201
Principal Investigator: Bal Raj Bhandari
Phone: 318-283-2177
Click here to add this to my saved trials
630 W 168th St
New York, New York
New York, New York
212-305-2862
Principal Investigator: Simon Lichtiger
Phone: 212-831-4900
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
Plymouth, Minnesota 55446
Principal Investigator: Robert P McCabe
Phone: 612-870-5599
Click here to add this to my saved trials
Rialto, California 92377
Principal Investigator: Zeid Kayali
Phone: 909-883-2999
Click here to add this to my saved trials
1045 East 3900 South
Salt Lake City, Utah 84124
Salt Lake City, Utah 84124
Principal Investigator: Peder J Pedersen
Phone: 801-893-1788
Click here to add this to my saved trials
San Antonio, Texas 78229
Principal Investigator: Nicholas P Martinez
Phone: 210-615-3848
Click here to add this to my saved trials